China Health Management Stock Price Prediction
CNHC Stock | USD 0.01 0.0006 10.91% |
Oversold Vs Overbought
46
Oversold | Overbought |
Using China Health hype-based prediction, you can estimate the value of China Health Management from the perspective of China Health response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in China Health to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying China because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
China Health after-hype prediction price | USD 0.008037 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
China |
China Health After-Hype Price Prediction Density Analysis
As far as predicting the price of China Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in China Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of China Health, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
China Health Estimiated After-Hype Price Volatility
In the context of predicting China Health's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on China Health's historical news coverage. China Health's after-hype downside and upside margins for the prediction period are 0.00 and 8.62, respectively. We have considered China Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
China Health is out of control at this time. Analysis and calculation of next after-hype price of China Health Management is based on 3 months time horizon.
China Health Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as China Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with China Health, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 8.61 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | In 5 to 10 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 31.75 |
|
China Health Hype Timeline
China Health Management is currently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. China is forecasted to increase in value after the next headline, with the price projected to jump to 0.008037 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is estimated to be 31.75%, whereas the daily expected return is currently at -0.2%. The volatility of related hype on China Health is about 143500.0%, with the expected price after the next announcement by competition of 0.01. The company has a current ratio of 1.07, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist China Health until it has trouble settling it off, either with new capital or with free cash flow. So, China Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Health Management sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Health's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out China Health Basic Forecasting Models to cross-verify your projections.China Health Related Hype Analysis
Having access to credible news sources related to China Health's direct competition is more important than ever and may enhance your ability to predict China Health's future price movements. Getting to know how China Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how China Health may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
BOXL | Boxlight Corp Class | (0.02) | 4 per month | 0.00 | (0.05) | 5.00 | (6.98) | 35.39 | |
SYTA | Siyata Mobile | (0.01) | 7 per month | 0.00 | (0.03) | 10.26 | (9.90) | 114.24 | |
CLRO | ClearOne | (0.02) | 3 per month | 0.00 | (0.15) | 4.17 | (3.92) | 15.98 | |
444859BR2 | HUMANA INC | 0.00 | 0 per month | 0.00 | (0.07) | 5.93 | (4.56) | 16.62 | |
AQUI | Aquagold International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
BRRAY | Barloworld Ltd ADR | 0.00 | 0 per month | 0.00 | (0.03) | 0.00 | (2.98) | 34.02 | |
MSTSX | Morningstar Unconstrained Allocation | 0.00 | 0 per month | 0.50 | (0.13) | 1.21 | (1.02) | 2.80 | |
ABHYX | High Yield Municipal Fund | (0.01) | 1 per month | 0.26 | (0.41) | 0.34 | (0.33) | 1.91 | |
LBHIX | Thrivent High Yield | 0.00 | 0 per month | 0.00 | (0.60) | 0.24 | (0.24) | 0.96 | |
SCAXF | Sparta Capital | 0.00 | 0 per month | 0.00 | (0.17) | 0.00 | 0.00 | 23.47 |
China Health Additional Predictive Modules
Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About China Health Predictive Indicators
The successful prediction of China Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as China Health Management, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of China Health based on analysis of China Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to China Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to China Health's related companies.
Story Coverage note for China Health
The number of cover stories for China Health depends on current market conditions and China Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that China Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about China Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for China Pink Sheet analysis
When running China Health's price analysis, check to measure China Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Health is operating at the current time. Most of China Health's value examination focuses on studying past and present price action to predict the probability of China Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Health's price. Additionally, you may evaluate how the addition of China Health to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |